# Alaska Online Public Notices #225596

Alaska Medicaid Drug Utilization Review Committee Public Meeting

**Posted:** October 20, 2026
**Identifier:** 225596

The State of Alaska’s Drug Utilization Review Committee is holding a public meeting on Medicaid drug utilization and pharmacy topics; this is not a procurement opportunity.
- **Government buyer:** State of Alaska, Department of Health, Division of Health Care Services, Pharmacy Services Unit.
- **Opportunity type:** Public committee meeting; no products or services are being purchased, and no quantities, part numbers, or contract value are stated.
- **Agenda topics:** Medicaid prescription and cost trends; medications and prior authorization, quantity-limit, and edit reviews; opioid-use trends; FDA and DEA updates; and FDA drug-safety and FAERS reports.
- **Named medications for review:** Icotyde, Nereus, Trutakna, Hympavzi, Xolair, and Zurzuvae.
- **OEMs and vendors:** No pharmaceutical manufacturers, vendors, or other companies are identified by name. Manufacturers may submit unsolicited clinical information related to agenda topics.

### Description

The State of Alaska Department of Health, Division of Health Care Services, is announcing a public meeting of the Drug Utilization Review Committee. The meeting will be held by teleconference on November 20, 2026, at 1:00 p.m., and registration is required to join the webinar. Agenda topics include Medicaid prescription and cost trends, new and existing prior authorizations and quantity limits, opioid use trends, and FDA/DEA updates. Pharmaceutical manufacturers may submit unsolicited agenda-related material by November 6, 2026, and members of the public may submit material by November 18, 2026.

[View original listing](https://aws.state.ak.us/OnlinePublicNotices/notices/View.aspx?id=225596)